Reportlinker Adds Chinese Markets for Cervical Cancer Treatment Drugs
|
| Posted
:
Tue, 03 Nov 2009 15:39:17 GMT |
| Author
:
Reportlinker |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
NEW YORK, Nov. 3 Reportlinker-Chna-rep
NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Chinese Markets for Cervical Cancer Treatment Drugs
http://www.reportlinker.com/p0157399/Chinese-Markets-for-Cervical-Cancer-Treatment-Drugs.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through 2013 and 2018 are presented. Major producers in China are profiled.
TABLE OF CONTENTS
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
Cervical Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Drivers
Cervical Cancer Treatment Drugs Industry Capacity
Major Producer Facility Locations and Output
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development
IV. CERVICAL CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
Overview
Demand of Pharmaceuticals by Region
Cervical Cancer Treatment Drugs Production and Demand
Alkylating Agent
Antimetabolisms
Antibiotic
Alkaloids Drugs
Other Cervical Cancer Treatment Drugs
Cervical Cancer Treatment Drugs Imports and Exports
Cervical Cancer Treatment Drugs Imports
Cervical Cancer Treatment Drugs Exports
Pricing Trend
IV. CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK
Cervical Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
VI. MARKETING STRATEGIES
China Market Entry Overview
China's Distribution System
Cervical Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China's Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise
VII. CERVICAL CANCER TREATMENT DRUGS PRODUCER DIRECTORY
Profiles of Cervical Cancer Treatment Drugs Producers and Major Suppliers
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
Cervical Cancer Treatment Drugs Industry Output
Major Producer Facility Location
Major Cervical Cancer Treatment Drugs Producer Output in 2008
All kinds of Cervical Cancer Treatment Drugs Market Share in 2008
Market Share of Key Producers in 2008
Major Foreign Investment in China in 2008
IV. CERVICAL CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
Cervical Cancer Treatment Drugs Production and Demand
Demand of Cervical Cancer Treatment Drugs by Region in 2008
Major Alkylating Agents Producer Output and Capacity in 2008
Alkylating Agents Production and Demand
Major Alkaloid Drugs Producer Output and Capacity in 2008
Alkaloid Drugs Production and Demand
Major Antibiotic Producer Output and Capacity in 2008
Antibiotic Production and Demand
Major Antimetabolisms Producer Output and Capacity in 2008
Antimetabolisms Production and Demand
Other Cervical Cancer Treatment Drugs Production and Demand
China Cervical Cancer Treatment Drugs Imports and Exports
V. CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK
Total Cervical Cancer Treatment Drugs Consumption by Market
All kinds of Cervical Cancer Treatment Drugs Market Share in 2008
China's Cervical Cancer Treatment Drugs Demand and Growth Rate
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
China's Cervical Cancer Treatment Capacity, Output, Demand
II. BUSINESS ENVIRONMENT
China's GDP and Growth Rate
Industrial Output by Ownership
China's Imports and Exports
III. CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
Cervical Cancer Treatment Drugs Capacity in China
All kinds of Cervical Cancer Treatment Drugs Market Share in 2008
Cervical Cancer Treatment Drugs Capacity, Output and Demand
IV. CERVICAL CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
Total Cervical Cancer Treatment Drugs Output and Demand
Total Cervical Cancer Treatment Drugs Import, Export and Net Import
V. CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK
Cervical Cancer Treatment Drugs Demand by Market in 2008
VI. MARKETING STRATEGIES
China's Distribution Channel
To order this report:
Chinese Markets for Cervical Cancer Treatment Drugs
http://www.reportlinker.com/p0157399/Chinese-Markets-for-Cervical-Cancer-Treatment-Drugs.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
More market research reports here!
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Apollo Successfully Completes Acquisition of Parallel Petroleum Corporation NEW YORK -
Parallel Petroleum Corporation and PLLL Holdings, LLC, an entity formed
for the purpose of acquiring Parallel Petroleum Corporation (NASDAQ:
PLLL) (“Parallel”), today announced the successful completion of the
merger of PLLL Acquisition Co. with and into Parallel, with
Borders(R) Has 50 Great Gifts at 50% Off for Black Friday
ANN ARBOR, Mich., Nov. 25 /PRNewswire/ -- Bargain-hunters will snap up some good deals at Borders stores nationwide on Black Friday and all through Thanksgiving weekend with the launch of 50 great gift items at 50% off the list price. Gifts at 50% off include some of this season's ...
CORRECTION FROM SOURCE: 2011 Buick Regal to be Built at the Oshawa Car Assembly Plant OSHAWA, ONTARIO -- 11/25/09 --
In the release sent earlier today at 10:30 am ET, there was an error in the fifth paragraph. It should have read: "The new Buick Regal joins the Chevrolet Equinox and the GMC Terrain..." instead of "The new Buick Rega..
Airvana Increases Mobile Broadband Capacity and Performance with EV-DO Release 8.0
CHELMSFORD, Mass., Nov. 25 -- Airvana, Inc. (Nasdaq: AIRV), today announced delivery of the latest release of its EV-DO Rev. A software. Release 8.0, which is now generally available, allows operators to increase the capacity and performance of their mobile b...
NADAguides.com to Make Big Announcement at Los Angeles International Auto Show
LOS ANGELES, Nov. 25 /PRNewswire/ -- NADAguides.com, the leading provider of pricing information and market research for cars, classics, RVs, motorcycles and boats, will be making big news at the Los Angeles International Auto Show. Although NADAguides.com has not released details o...
Fitch Rates Piedmont Muni Power Agency's (South Carolina) $217.17MM Electric Revs 'BBB+' NEW YORK -
Fitch Ratings assigns a 'BBB+' rating to the following 2009 series of
Piedmont Municipal Power Agency's (PMPA) electric system revenue bonds:
--$13.210 million Series 2009A-1 (federally taxable);
--$20,220 million Series 2009A-2;
Fitch Rates Muni Bldg Auth of Salt Lake County's (UT) $84.1MM Lease Revs 'AA+'; Upgrades Outstanding SAN FRANCISCO -
Fitch Ratings assigns an 'AA+' rating to the Municipal Building
Authority of Salt Lake County's (Utah) $84.1 million lease revenue
bonds, series 2009A and 2009B (Federally Taxable - Issuer Subsidy -
Build America Bonds). Fitch also upgrades its rating to 'AA+' from 'AA'
|
|
|
|
|
|
|
|
|